Bupropion (Zyban): First results of an independent clinical management study;Bupropion (Zyban): Erste resultate einer independent clinical management study

Sucht

Volumn 46, Issue 6, 2000, Pages 408-413

  Groman, E ^a   Bayer, P ^a   Kiefer, I ^a   Eckl Dorna, J ^a   Schoberberger, R ^a  

^a Nikotin Institut Wien   (Austria)

Author keywords

Bupropion; Nicotine dependence; Smoking cessation

Indexed keywords

AMFEBUTAMONE; NICOTINE;

ADULT; ARTICLE; CARBON MONOXIDE INTOXICATION; DRUG DEPENDENCE; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; INSOMNIA; MAJOR CLINICAL STUDY; MALE; SMOKING CESSATION; SMOKING HABIT; SWEATING; TREATMENT CONTRAINDICATION; XEROSTOMIA;

EID: 0034456347     PISSN: 09395911     EISSN: None     Source Type: Journal    
DOI: 10.1024/suc.2000.46.6.408     Document Type: Article

References (9)

1. Scientific and ethical issues in the use of placebo controls in clinical trials
2. Nicotine addiction and its assessment
3. Nicotine dependence versus smoking prevalence: Comparison among countries and categories of smokers
4. A comparison of sustained-release bupropion and placebo for smoking cessation
5. A controlled trial of sustained-release bupropion, a nicotine patch or both for smoking cessation
6. Maximizing help for dissonant smokers
7. Wiener standard zur diagnostik der nikotinabhängigkeit: Wiener standard raucherinventar (WSR)
8. Bupropion is a nicotinic antagonist
9. Recycling with nicotine patches in smoking cessation